Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-846-0 | CAS number: 22221-10-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
skin corrosion/irritation: not irritating (OECD 404; GLP)
Eye irritation: serious eye damaging (OECD 437, GLP)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2018-07-30 to 2018-08-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Version / remarks:
- 2015-07-28
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2018-04-26
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature, closed, dry - Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, 97633 Sulzfeld, Germany
- Age at study initiation: approx 43 and 56 - 57 weeks old
- Weight at study initiation: 4.0 – 4.7 kg
- Housing: individually housed in ABS-plastic or Noryl rabbit cages, floor 4200 cm2
- Diet (ad libitum): autoclaved hay and Altromin 2123 maintenance diet for rabbits, rich in crude fibre
- Water (ad libitum): tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 18 ± 3 °C
- Relative humidity: 55 ± 10 %
- Air changes: at least 10 x / hour
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Preparation of test site:
- clipped
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.5 g of the test item
In order to ensure good skin contact, it was moistened with aqua ad injectionem. - Duration of treatment / exposure:
- initial animal: 3 minutes, 1 hour and 4 hours
confirmatory animal: 4 hours - Observation period:
- Initial animal: 6 days
Confirmatory animal: 7 days - Number of animals:
- 2 male rabbits
- Details on study design:
- TEST SITE
Area of exposure/Type of wrap if used: approx. 24 hours before the test, the fur was removed from the dorsal area of the trunk by using an electric clipper. The test item was applied to a small area (approx. 6 cm²) of skin on one side of the dorsal area and covered with a gauze patch, which was held in place with a non-irritating tape. The untreated other side served as control. The test item was applied to the patch first, moistened with the smallest amount of aqua ad injectionem and then applied to the skin. The patch was fixed with a semi-occlusive dressing. The limits of the application site were marked with an ink marker.
INITIAL AND CONFIRMATORY TESTING
As the test item is expected to produce severe irritancy/corrosion, a single animal test was employed. Up to three test patches were applied sequentially to the animal. The first patch was removed after three minutes. No serious skin reaction was observed, so a second patch was applied at a different site and removed after one hour. The observations at this stage indicated that exposure can humanely be allowed to extend to four hours, so a third patch was applied and removed after four hours, and the response was graded. No corrosive effect was observed after the last patch was removed, so the animal was further observed.
The results of the initial test indicated that the test item is not corrosive to the skin using the procedure described. In order to confirm the reversible irritant response, one additional animal was treated in the same manner. According to OECD 404, section 17, treatment of a third animal can be omitted when animal no. 1 and 2 exhibit the same response. Furthermore, according to the classification directives, the results of animal no. 1 and 2 were sufficient for classification of the test item. Moreover, as the test item showed no signs of corrosion in two animals and full reversibility of the effects, it is considered that adding a third animal would not change the outcome of the study.
REMOVAL OF TEST SUBSTANCE
At the end of the exposure period, the residual test item was removed with sterile water from animal no. 1. As the test item showed a water-repellent effect, an appropriate solvent, cottonseed oil was subsequently used to remove residual test material from animal no.1 and immediately after patch removal from animal no. 2. Cottonseed oil was chosen in order not to alter the existing response or the integrity of the epidermis. For animal no. 1, this was repeated 24 hours after application as test item residues were still observed at the application site.
OBSERVATION TIME POINTS
- initial animal: immediatley and 1 hour, 24, 48,72 and 96 hours after patch removal
- confirmatory animal: 1 hour, 24, 48 and 72 hours after patch removal
SCORING SYSTEM
according to the Draize scale
FURTHER OBSERVATIONS
- body weights: prior to the administration and at the end of the observation period
- local effects such as hyperplasia, scaling, discolouration, fissures and scabs
- systemic effects - Irritation parameter:
- erythema score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- other: 48/ 72/ 96 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 6 days
- Remarks on result:
- other: Due to delayed symptom onset, the mean score is calculated from the values 48, 72 and 96 hours after patch removal
- Irritation parameter:
- edema score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Irritation parameter:
- erythema score
- Basis:
- mean
- Remarks:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- edema score
- Basis:
- mean
- Remarks:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Irritant / corrosive response data:
- INITIAL ANIMAL:
After patch removal during and immediately after sequential application (3 min, 1 hour, 4 hours) no signs of irritation were noted in animal no. 1. A delayed onset was noted though: erythema grade 1 was first observed 48 hours after patch removal and thereafter at daily observation until day 5. The effect was reversible within day 6 after application of the test material.
CONFIRMATION ANIMAL:
Animal no. 2 showed erythema grade 1 at 24 and 48 hours after patch removal. Erythema was increased to grade 2 at 72 hours and 96 hours after patch removal, before it was decreased again on day 5 and day 6 post-application (score 1). The effects disappeared within 7 days after application.
The single dermal application of 0.5 g Copper 2-ethylhexanoate to two rabbits showed irritant (very slight erythema, grade 1.00 and 1.33) but not corrosive effects. In both animals these findings were reversible. - Other effects:
- - Neither mortalities nor local or systemic effects were observed.
- There were no significant body weight changes during the observation period
- A slight turquoise discolouration of the application site due to residual test item was noted during sequential application in animal no. 1 and up to 24 hours after patch removal in both animals.
- The body weight development was within the expected range. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item is not irritating to the skin.
According to Regulation (EC) No 1272/2008 and subsequent adaptations, the substance does not require classification as skin irritant.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-04-11
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2017-10-09
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2015-06-05
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: ambient temperature, closed, dry - Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: abattoir A. Moksel AG, Buchloe, Germany
- Storage, temperature and transport conditions of ocular tissue: fresh eyes were collected from the slaughterhouse and were transported in HBSS containing Pen/Strep on ice to the laboratories
- Time interval prior to initiating testing: immediately after arrival of the eyes, cornea preparation was initiated and was used for BCOP testing on the same day. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Preparation of the test item: Since it was not possible to get a solution with the test item, about 750 mg test item was administered directly and moistened with a drop of physiological saline (0.9% NaCl). - Duration of treatment / exposure:
- 4 hours
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- not required
- Number of animals or in vitro replicates:
- Number of bovine corneae per dose:
Test item: triplicates
Negative control: triplicates
Positive control: triplicates - Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
- eyes were examined for defects and any defective eyes were discarded. Eyes with scratches or any kind of opacity were not used.
- tissue surrounding the eyeball was pulled away and the cornea was excised.
- isolated corneas were stored in a petri dish containing HBSS. Before mounting the corneas in corneal holders (BASF, Duratec GmbH) with the endothelial side against the O-ring of the posterior chamber, they had been visually examined for defects and any defective cornea had been discarded. The anterior chamber was then positioned on top of the cornea and tightened with screws. The chambers of the corneal holder were then filled with MEM (without phenol red) containing 1 % FBS and 2 mM L-glutamine (complete MEM).
- corneas were incubated for one hour at 32 ± 1 °C for equilibration in an air incubator.
QUALITY CHECK OF THE ISOLATED CORNEAS
- after the equilibration period, the medium was removed from both chambers and replaced with fresh complete MEM.
- an initial measurement was performed on each of the corneas using the opacitometer.
- three corneas with illuminance readings approximately equivalent to the median illuminance of all corneas were selected as negative-control corneas.
- the illuminance of each cornea was read and recorded.
- only corneas that had an initial illuminance reading I > I0/1.1651 lux (an equivalent to the opacity threshold of 7 as listed in OECD 437) were used for the assay.
APPLICATION DOSE AND EXPOSURE TIME
- medium was removed from the anterior chamber and replaced with the test item or control.
- about 750 mg test substance or 750 μL of the control substance was introduced into the anterior chamber (closed-chamber method).
- after 4 hours and 2 minutes incubation at 32 ± 1 °C either the test substance or the control substance was removed.
REMOVAL OF TEST SUBSTANCE/CONTROL SUBSTANCES
- substance was removed and the epithelium washed more than three times with MEM (containing phenol red), since a little bit of residual test material could not be removed. The cornea was finally rinsed with complete MEM (without phenol red).
METHODS FOR MEASURED ENDPOINTS:
- anterior chamber was refilled with complete MEM and an illuminance measurement was performed.
- each cornea was observed visually and pertinent observations were recorded.
- corneas were visually examined for tissue peeling, residual test chemical and non-uniform opacity patterns and observation were recorded.
- after the illuminance measurement was performed, the permeability was measured.
- the medium was removed from both chambers of the holder.
- posterior chamber was refilled with fresh complete MEM.
- 1 mL of a 5 mg/mL sodium fluorescein solution was added to the anterior chamber and the corneas were incubated for 90 minutes at 32 ± 1 °C.
- then the medium from the posterior chamber was removed and its optical density at 490 nm (OD490) was determined, using a spectrophotometer (Jenway 6405 UV/VIS).
Evaluation of the opacity:
- the following formula was used to calculate the opacity, whereas the values a and b are equipment-specific variables empirically determined by the manufacturer:
Opacity = ((I0/I) - b)/ a
with a = 0.025 and b = 0.9894
- value I0 is the illuminance through a holder without cornea, but with windows and liquid. This value is determined by taking the mean for a set of cornea holders and is reevaluated periodically. This I0 value was than calculated to the respective data of the opacitometer and the data according to guideline (opacity < 7). So the initial illuminance could be calculated and corneas below this value were discarded.
- change in opacity for each cornea (test item, positive and negative control) was calculated by subtracting the initial opacity reading from the final opacity reading. These values of test item treated cornea or positive control were corrected by subtracting from each the average change in opacity observed for the negative-control corneas to obtain the corrected opacity. The mean corrected opacity value for the negtive control and the mean corrected opacity value for the test item and the positive control was calculated by averaging the corrected opacity values of each cornea for a given treatment.
Evaluation of the permeability:
- mean OD490 for the blank cuvettes was calculated.
- mean blank OD490 was subtracted from the OD490 of each cuvette (corrected OD490).
- any dilutions that were made to bring the OD490 values into the linear range of the spectrophotometer (OD490 should be less than 1.500), were taken into account by multiplying the OD490 value of the dilution by the dilution factor.
- final-corrected OD490 of the test article and the positive control were calculated by subtracting the average-corrected OD490 of the negative-control corneas from the corrected OD490 value of each treated cornea:
Final-corrected OD490 = (OD490 – mean blank OD490) – average-corrected negative control OD490
- mean OD490 value of each treatment group was calculated by averaging the final corrected OD490 values of the treated corneas for that treatment condition.
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
The following formula was used to determine the in vitro irritation score (IVIS):
IVIS = mean opacity value + (15 x mean permeability OD490 value)
To determine the IVIS of the positive control and the test item, the corrected opacity and OD490 values were used.
For the IVIS cut-off values for identifying test substances as inducing serious eye damage and test substances not requiring classification for eye irritation or serious eye damage please refer to table 1 in the field "Any other information onmaterial and methods incl. tables" below.
ACCEPTABILITY CRITERIA
- the BCOP assay is considered to be valid if the in vitro irritation score obtained with the positive control falls within the two standard deviations of the current historical mean.
- the negative control responses should result in opacity and permeability values that are less than the established upper limits for background bovine corneas treated with the respective negative control. - Irritation parameter:
- in vitro irritation score
- Remarks:
- (mean)
- Value:
- 65.58
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- - Since it was not possible to get a solution with the test item, it was administered directly and moistened with a drop of physiological saline (0.9% NaCl).
- Other effects / acceptance of results:
- Visual Observation after treatment:
All 3 corneas treated with copper 2-ethylhexanoate showed very strong opacity of the tissue. Little parts of test material could not be completely washed off the cornea.
The experiment showed residual Copper 2-ethylhexanoate on the corneas. The results of the opacity measurements are therefore confounded by the presence test item material. Since the residual material could not be removed by non-invasive methods, such as additional rinsing, it is concluded that the in vitro eye irritancy potential of Copper 2-ethylhexanoate cannot be assessed in the bovine corneal opacity and permeability assay. Due to these technical limitations, the study cannot be performed with Copper 2-ethylhexanoate according to the guideline OECD437. However, based on the qualitative visual appraisal of the cornea being markedly opaque, a conservative classification of Copper 2-ethylhexanoate being severely damaging to eye (H318) appears justified.
Measurement after treatment:
Relative to the negative control, the test item caused a severe increase of corneal opacity and a slight increase of permeability in all 3 corneas.
Acceptance of results:
- Acceptance criteria met for negative control: the negative control responses resulted in opacity and permeability values that are less than the respective established upper limits for background opacity and permeability.
- Acceptance criteria met for positive control: the IVIS of the positive control falls within two standard deviations of the current historical mean
Please also refer for results to the field "Any other information on results incl. tables" below - Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Conclusions:
- The in vitro eye irritancy potential of Copper 2-ethylhexanoate cannot be assessed in the bovine corneal opacity and permeability assay due to residual test item on the cornea, confounding the transmission measurements. However, based on the qualitative visual appraisal of the cornea being markedly opaque, a conservative classification of Copper 2-ethylhexanoate being severely damaging to eye (H318) appears justified.
In conclusion, Copper 2-ethylhexanoate needs to be classified as serious eye damaging (EU CLP/ UN GHS Category 1).
Reference
Table 1: Opacity
Cornea No. |
Test Item |
Initial Opacity |
Final Opacity |
Change of Opacity Value |
Corrected Opacity Value |
1 |
Negative Control |
0.22 |
0.80 |
0.58 |
|
2 |
0.19 |
0.19 |
0.00 |
|
|
3 |
0.25 |
-0.08 |
-0.33 |
|
|
MV |
0.22 |
0.30 |
0.08 |
|
|
4 |
Positive Control |
0.87 |
99.43 |
98.56 |
98.48 |
5 |
1.65 |
93.50 |
91.85 |
91.77 |
|
6 |
0.83 |
95.03 |
94.19 |
94.11 |
|
MV |
1.12 |
95.99 |
94.87 |
94.79 |
|
7 |
Test Item |
-0.54 |
52.42 |
52.96 |
52.88 |
8 |
0.29 |
43.15 |
42.87 |
42.79 |
|
9 |
0.63 |
54.26 |
53.64 |
53.55 |
|
MV |
0.12 |
49.95 |
49.82 |
49.74 |
MV = mean value
Table 2: Permeability
Cornea No. |
Test Item |
OD490 |
Corrected OD490 Value |
1 |
Negative Control |
0.018 |
|
2 |
0.023 |
|
|
3 |
0.012 |
|
|
MV |
0.018 |
|
|
4 |
Positive Control |
1.123 |
1.105 |
5 |
2.035 |
2.017 |
|
6 |
2.330 |
2.312 |
|
MV |
1.829 |
1.812 |
|
7 |
Test Item |
1.105 |
1.087 |
8 |
0.940 |
0.922 |
|
9 |
1.177 |
1.159 |
|
MV |
1.074 |
1.056 |
MV = mean value
Table 3: In vitro irritation score
Cornea No. |
Test Item |
Corrected Opacity |
Corrected OD490 Value |
IVIS |
1 |
Negative Control |
0.58 |
0.018 |
|
2 |
0.00 |
0.023 |
|
|
3 |
-0.33 |
0.012 |
|
|
MV |
0.08 |
0.018 |
0.35 |
|
4 |
Positive Control |
98.48 |
1.105 |
|
5 |
91.77 |
2.017 |
|
|
6 |
94.11 |
2.312 |
|
|
MV |
94.79 |
1.812 |
121.96 |
|
7 |
Test Item |
52.88 |
1.087 |
|
8 |
42.79 |
0.922 |
|
|
9 |
53.55 |
1.159 |
|
|
MV |
49.74 |
1.056 |
65.58 |
MV = mean value
Table 4: Historical mean in vitro irritation score of the positive control from February 2015 until March 2018
|
IVIS Positive Control - Imidazole 20 % |
|
Mean Value (MV) |
123,27 |
|
Standard Deviation (SD) |
17,42 |
|
MV- 2xSD |
88,43 |
|
MV+2xSD |
158,12 |
|
Number of Replicates providing Historical Mean: 35 |
||
Positive controls are updated after every single experiment or at least every 3 months
Table 5: Historical data on opacity and permeability of the positive control (Imidazole 20 %) from August 2017 until March 2018
Number of Replicates Providing Historical Mean |
Cornea No. |
Opacity |
Permeability |
IVIS |
|||
Change of |
Corrected |
OD490 Value |
Corrected |
||||
2017 |
1 |
4 |
122.785 |
121.861 |
0.662 |
0.624 |
133.420 |
|
5 |
117.173 |
116.249 |
1.220 |
1.182 |
||
|
6 |
102.655 |
101.731 |
2.260 |
2.222 |
||
|
2 |
4 |
108.553 |
106.381 |
1.473 |
1.450 |
123.050 |
|
5 |
79.491 |
77.319 |
2.465 |
2.442 |
||
|
6 |
83.618 |
81.446 |
3.065 |
3.042 |
||
3 |
4 |
55.644 |
56.308 |
2.200 |
2.189 |
92.540 |
|
5 |
71.511 |
72.175 |
1.348 |
1.337 |
|||
6 |
65.148 |
65.812 |
2.040 |
2.029 |
|||
|
4 |
4 |
68.39 |
67.72 |
2.400 |
2.383 |
112.690 |
|
5 |
70.88 |
70.21 |
2.810 |
2.793 |
||
|
6 |
94.23 |
93.56 |
1.945 |
1.928 |
||
|
5 |
4 |
70.53 |
70.35 |
1.296 |
1.284 |
102.440 |
|
5 |
78.68 |
78.50 |
1.363 |
1.351 |
||
|
6 |
91.69 |
91.51 |
1.840 |
1.828 |
||
2018 |
6 |
4 |
95.54 |
94.92 |
1.478 |
1.467 |
114.650 |
|
5 |
83.58 |
82.96 |
1.500 |
1.489 |
||
|
6 |
91.11 |
90.49 |
2.095 |
2.084 |
||
|
7 |
4 |
89.35 |
88.86 |
2.855 |
2.838 |
149.420 |
|
5 |
117.36 |
116.87 |
2.215 |
2.198 |
||
|
6 |
130.15 |
129.66 |
2.505 |
2.488 |
||
|
8 |
4 |
80.99 |
80.24 |
2.140 |
2.127 |
120.110 |
|
5 |
78.40 |
77.65 |
3.070 |
3.057 |
||
|
6 |
76.27 |
75.51 |
3.290 |
3.277 |
||
Mean Value (MV) |
88.488 |
87.846 |
2.064 |
2.046 |
118.540 |
||
Standard Deviation (SD) |
19.507 |
19.246 |
0.679 |
0.681 |
17.657 |
||
MV- 2xSD |
49.474 |
49.354 |
0.706 |
0.685 |
83.226 |
||
MV+2xSD |
127.502 |
126.339 |
3.422 |
3.408 |
153.854 |
Table 6: Historical mean in vitro irritation score of the negative control from February 2015 until March 2018
|
IVIS Negative Control - NaCl 0.9 % |
|
Mean Value (MV) |
1.08 |
|
Standard Deviation (SD) |
0.77 |
|
MV- 2xSD |
-0.47 |
|
MV+2xSD |
2.62 |
|
Number of Replicates providing Historical Mean: 35 |
||
Negative controls are updated after every single experiment or at least every 3 months.
Table 7: Historical data on opacity and permeability of the negative control (NaCl 0.9 %) from August 2017 until March 2018
Number of Replicates Providing Historical Mean |
Cornae No. |
Opacity |
Permeability |
IVIS |
|
Change of |
OD490 Value |
||||
2017 |
1 |
1 |
0.234 |
0.008 |
1.49 |
2 |
1.738 |
0.008 |
|||
3 |
0.800 |
0.098 |
|||
2 |
1 |
0.978 |
0.019 |
2.52 |
|
2 |
3.920 |
0.022 |
|||
3 |
1.617 |
0.028 |
|||
3 |
1 |
-0.149 |
0.009 |
-0.50 |
|
2 |
-0.415 |
0.015 |
|||
3 |
-1.427 |
0.009 |
|||
4 |
1 |
0.776 |
0.008 |
0.92 |
|
2 |
0.808 |
0.022 |
|||
3 |
0.418 |
0.020 |
|||
5 |
1 |
0.035 |
0.010 |
0.35 |
|
2 |
0.036 |
0.013 |
|||
3 |
0.466 |
0.012 |
|||
2018 |
6 |
1 |
1.030 |
0.017 |
0.79 |
2 |
0.190 |
0.008 |
|||
3 |
0.640 |
0.009 |
|||
7 |
1 |
0.714 |
0.024 |
0.74 |
|
2 |
0.373 |
0.015 |
|||
3 |
0.371 |
0.012 |
|||
8 |
1 |
1.034 |
0.013 |
0.94 |
|
2 |
0.596 |
0.01 |
|||
3 |
0.623 |
0.015 |
|||
Mean Value (MV) |
0.650 |
0.019 |
0.928 |
||
Standard Deviation (SD) |
1.097 |
0.021 |
1.024 |
||
MV- 2xSD |
-1.543 |
-0.023 |
-1.120 |
||
MV+2xSD |
2.843 |
0.060 |
2.976 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irreversible damage)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin corrosion/irritation:
The substance is either corrosive or irritating to the skin (OECD 439; GLP). Since the RhE test methods covered by OECD TG 439 cannot resolve between UN GHS Categories 1 or 2, a follow-up study was conducted according to OECD 435 (GLP). However, the OECD 435 test method was not applicable, since the receptor fluid was not activated by the test substance. Thus, an in vivo skin irritation study (OECD 404; GLP) was conducted. In this study, the substance displayed no irritating properties to the skin.
Eye irritation:
The substance was observed to be serious eye damaging in an in vitro eye irritation study according to OECD 437.
Justification for classification or non-classification
Skin irritation:
2-ethylhexanoic acid, copper salt does not possess a skin irritating potential based on an in vivo OECD 404 test and does not require classification according to Regulation (EC) No 1272/2008 and its subsequent adaptations.
Eye irritation:
2-ethylhexanoic acid, copper salt does possess a serious eye damaging potential based on an in vitro OECD 437 test and does require classification as serious damaging to the eyes according to Regulation (EC) No 1272/2008 and its subsequent adaptations (Category 1; H318).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.